Showing results (211-220 of 418) with videos related to

Sort By:
Pageof 42
Forensic Science International|April 9, 2011
Desorption atmospheric pressure photoionization-mass spectrometry in routine analysis of confiscated drugsTiina J Kauppila, Anu Flink, Markus Haapala, et al.
Molecular Cancer Therapeutics|July 12, 2019
A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab EmtansineVadim Le Joncour, Ana Martins, Maija Puhka, et al.
Molecular Pharmacology|June 1, 1996
Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormoneL Laakkonen, W Li, J H Perlman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2020
Hypoxia-Mediated Regulation of Histone Demethylases Affects Angiogenesis-Associated Functions in Endothelial CellsOscar Hsin-Fu Liu, Miika Kiema, Mustafa Beter, et al.
Plos One|October 3, 2012
Transcellular targeting of fiber- and hexon-modified adenovirus vectors across the brain microvascular endothelial cells in vitroJohanna P Laakkonen, Tatjana Engler, Ignacio A Romero, et al.
The Journal of Surgical Research|March 4, 2023
Nondestructive Evaluation of Mechanical and Histological Properties of the Human Aorta With Near-Infrared SpectroscopyJaakko K Sarin, Miika Kiema, Emma-Sofia Luoto, et al.
Clinical & Experimental Metastasis|February 17, 2024
Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis modelNegar Pourjamal, Narjes Yazdi, Aleksi Halme, et al.
Trials|October 8, 2010
Exercise rehabilitation on home-dwelling patients with Alzheimer's disease--a randomized, controlled trial. Study protocolKaisu H Pitkala, Minna M Raivio, Marja-Liisa Laakkonen, et al.
The Journal of Clinical Investigation|March 17, 2007
Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomasGrzegorz Sarek, Sari Kurki, Juulia Enbäck, et al.
Oncotarget|February 27, 2016
Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progressionJohanna Eriksson, Vadim Le Joncour, Pirjo Nummela, et al.
Pageof 42